We read the clinical evidence before we read the price list.
Tidewater Sciences is an independent sourcing and evaluation firm for buyers of medical devices, in-vitro diagnostics, laboratory equipment, and life-science consumables. We identify overseas manufacturers, work through the technical and clinical evidence behind their products, and hand buyers a shortlist they can defend to a procurement committee, a regulator, or their own clinical staff.
What sits between a manufacturer's catalog and a purchase order
Most sourcing decisions in medical devices and diagnostics still start from the wrong document. A distributor sends a catalog, a manufacturer sends a datasheet, and a buying committee is asked to compare products on the strength of marketing copy and a list price. The clinical and technical file that actually supports the manufacturer's claims, the analytical validation study behind a diagnostic's sensitivity and specificity, the design history file behind a device's classification, the audit history behind a factory's quality system, rarely reaches the desk of the person making the decision. Tidewater Sciences exists to close that gap. We work upstream of any purchase order: identifying candidate manufacturers in a product category, pulling together the evidence that supports their claims, and evaluating that evidence against the buyer's actual clinical and regulatory requirements.
We do not distribute product, hold inventory, arrange freight, or clear customs. Sourcing, in our use of the word, means diligence: finding out who can credibly supply a product category, and which of the credible candidates actually performs the way its literature says it does. What a buyer does after receiving our shortlist, whether that is direct import, a distributor relationship, or a tender submission, is a separate decision that belongs to them.
Services
Technical and clinical product evaluation, manufacturer quality-system review, regulatory pathway mapping, and comparative shortlisting, described in full on the services page.
Approach
How an engagement actually runs, from scoping the requirement through to a defensible shortlist report, and what we ask of the buyer along the way.
Sectors
The product categories we work in: medical devices, in-vitro diagnostics, laboratory equipment and reagents, and life-science consumables.
Independence is a structural choice, not a marketing line
A distributor is paid on the products it moves. A manufacturer's regional agent is paid to represent that one manufacturer well. Neither is positioned to tell a buyer that a competing product performs better on the metric that actually matters for a given clinical setting. That is not a criticism of distributors or agents; it is simply the incentive structure they operate under, and buyers should account for it when weighing what those parties recommend.
Tidewater Sciences is paid by the buyer, for the evaluation, regardless of which product ends up on the shortlist or whether any product does. We hold no distribution rights, no manufacturer commissions, and no equity or referral arrangement with any supplier we evaluate. When a manufacturer's product does not hold up under review, our report says so, and the manufacturer does not see the report before the client does.
A shortlist is only as useful as the evidence behind it. Our work product is not a preference; it is a file a buyer can hand to a technical committee, a tender evaluator, or their own regulatory affairs staff and have it hold up to questions.
We are organized as a U.S. Virgin Islands limited liability company, a U.S. territory. More on why that structure matters for a buyer working across borders is covered on the About page.
Who brings us in
The buyers we work best with are the ones who already know that a lower quote is not the same as a lower total cost, and that a product's marketing datasheet is not the same as its clinical validation. That includes hospital and laboratory procurement teams evaluating multiple candidate suppliers for a tender or a capital purchase, importers and distributors who want a second technical opinion before they commit to representing a manufacturer, and group purchasing or category managers who need to defend a recommendation to a clinical or scientific committee. In every case, the work product is the same: a clear, sourced, comparative evaluation that the buyer can stand behind.
If a category is new to you, or the field of candidate manufacturers is larger than your team has time to work through, that is precisely the situation this firm is built for. Get in touch and describe the product category and the decision you are trying to make; we will tell you plainly whether an evaluation engagement is the right next step.